The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This is a study for patients who have been previously treated for NHL. The purpose of this
study is to determine the safety and feasibility of double-target CART-19 and 20 cells to the
patients with relapsed and refractory CD19+/CD20+ NHL.